Product Development

Technical
Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseasesSparrow, E., M. Friede, M. Sheikh, and S. Torvaldsen. “Therapeutic Antibodies for Infectious Diseases.” Bulletin of the World Health Organization 95, no. 3 (2017):235–237....
Features
Medical treatments and pharmaceuticals are indispensable in improving quality of life. In recent years, however, pharmaceutical compounds have become a significant group of environmental pollutants, shown to pose risks to human health and have adverse environmental effects.
Video
Complimentary One Size Does Not Fit All: Strategies for Bringing Advanced Therapy Medicinal Products to Market The number of advanced therapy medicinal products (ATMP) on the global market is fewer than expected despite...
iSpeak Blog
Introduction Patients are demanding more innovation from drug companies for delivery of therapeutics, ease of use, and affordability. Combination Products are integral to our industry. Per the Globe Newswire Global Forecast, the Drug Device Combination...
Insights
Initially, the American College of Rheumatology urged caution around the use of biosimilars. Information about the manufacturing process for a branded biologic is proprietary; a biosimilar manufacturer will not have access to the details of the process, so how could they guarantee their product...